Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the healthcare sector, is capturing the attention of investors with its innovative approach to physician enablement and a promising potential..
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is a dynamic player in the biotechnology sector, headquartered in Cambridge, Massachusetts. The company is renowned for its innovative approach to developing therapies in the..
Viridian Therapeutics, Inc. (NASDAQ: VRDN) has emerged as a compelling player in the biotechnology sector with its innovative approach to addressing serious and rare diseases. With a market capitalization of..
Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing investor interest with its significant growth potential in the biotechnology sector. The company, with its $4.44 billion market cap, is a clinical-stage biopharmaceutical..
Evotec SE (EVO) presents a compelling case for investors willing to navigate the complexities of the healthcare sector, specifically within drug manufacturing. Headquartered in Hamburg, Germany, Evotec operates in both..
Dynavax Technologies Corporation (NASDAQ: DVAX) is making waves in the healthcare sector with a robust focus on vaccine development and commercialization. As a commercial-stage biopharmaceutical company, Dynavax has carved a..
Pulse Biosciences, Inc (NASDAQ: PLSE), a burgeoning player in the healthcare sector, is making waves in the medical instruments and supplies industry with its innovative bioelectric medicine technologies. Headquartered in..
Progyny, Inc. (NASDAQ: PGNY), a healthcare plans company specializing in fertility and family-building benefits, is drawing attention with a notable potential upside of 68.39%, according to current analyst ratings. As..
Vera Therapeutics, Inc. (NASDAQ: VERA), a biotechnology company strategically positioned in the healthcare sector, is catching the eye of investors with a striking potential upside of 94.88%. Despite a modest..
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is gaining traction among investors as a promising player in the biotechnology sector. With a current market cap of $2.9 billion, this precision medicine oncology..
For investors seeking opportunities in the healthcare sector, ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presents a compelling case. With a potential upside of 47.07%, as indicated by analysts’ average target price,..
Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a pioneering entity in the biotechnology sector, is garnering attention with its robust 29.39% potential upside, according to recent analyst ratings. With its headquarters nestled..
Haemonetics Corporation (NYSE: HAE), a prominent player in the medical devices industry, is capturing investor attention with a compelling potential upside of 37.76%. Known for its innovative suite of hospital..
Travere Therapeutics, Inc. (NASDAQ: TVTX), a prominent player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 44.65% based on current analyst ratings. This San..
Investors eyeing the healthcare sector may find ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) an intriguing prospect. With a market capitalization of $3.86 billion, ACADIA stands as a significant player in the..
Twist Bioscience Corporation (NASDAQ: TWST) is making waves in the healthcare sector, specifically within the diagnostics and research industry, as it continues to capture the interest of investors with its..
Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a biotechnology firm specializing in peptide-based therapeutics, is capturing investor attention with its dynamic pipeline and robust analyst support. With a market capitalization of $6.01..
Premier, Inc. (NASDAQ: PINC) stands as a notable player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $2.34 billion, Premier, Inc. operates..
QuidelOrtho Corporation (NASDAQ: QDEL) is a compelling entity within the healthcare sector, focusing on medical devices. With a market capitalization of $1.54 billion, the company specializes in diagnostic testing solutions,..
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a promising player in the biotechnology sector, is garnering attention from investors with its significant 40.35% potential upside, as indicated by current analyst target prices...
